Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Atomic Force Microscope

By Drug Discovery Trends Editor | July 21, 2008

Agilent Technologies Inc. offers the Agilent 5600LS, a high-resolution atomic force microscope that uses a fully addressable 200mm x 200mm stage to image large samples in air or smaller samples in liquid. The 5600LS also enables high-resolution imaging of a small sample area using an AFM or STM scanner. Its new, low-noise AFM design (.05nm) guarantees single atomic steps.

Samples up to 8 inches in diameter and 30mm tall are easily accepted by the 5600LS AFM’s 200mm vacuum chuck; the programmable stage can accommodate a 300mm wafer with repositioning. Accurate location mapping (400nm precision) ensures reproducibility. The 5600LS also allows simple, software-driven, point-and-shoot AFM imaging of an area of interest based on an optical view. Motorized optical zoom and focus provide excellent ease-of-use.

Any of Agilent’s multipurpose scanners, including open-loop, closed-loop and STM options, can be used with the 5600LS. Open-loop and closed-loop Agilent multipurpose scanners are available in two scan ranges: 90ìm x 90ìm, or 9ìm x 9ìm. Interchangeable scanner nose cones let users switch imaging modes quickly and conveniently.

The Agilent 5600LS is compatible with contact mode, acoustic AC mode, phase imaging, STM, LFM, EFM, MFM, force modulation, current sensing and MAC Mode III. Agilent’s patented MAC Mode III provides three user-configurable lock-in amplifiers, affording researchers virtually limitless application possibilities and unprecedented speed. It allows single-pass imaging concurrent with KFM/EFM, facilitates vertical or lateral modulation studies, and supports the use of higher resonance modes of the cantilever.

Agilent Technologies


Filed Under: Drug Discovery

 

Related Articles Read More >

NIH is reorganizing clinical trial funding by trial type instead of disease
Chemical formula of psilocybin
Psychedelic pioneer Compass files for FDA approval as rivals close in
Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE